Florian Kemmerich

Florian Kemmerich began their career in 2014 as a Partner at PARTER Capital Group. In 2015, they became the Owner of Ryan-Kay, and was also appointed to the Translational Advisory Board of the European Commission. Florian also joined OrthoSera GmbH as a Board Member in 2015 and Co-Founded Histide in the same year. In 2016, Florian became the Chairman of LIFNano Therapeutics and Managing Partner of Bamboo Capital Partners. In 2019, they were appointed to the Board of BBOXX, and in 2020 they became the Chair of the Impact Networks Council and Member of the Networks Committee at YPO. In 2022, Florian became an Investor at pyrpose.

Florian Kemmerich began their educational journey in 1986 at the Heinrich Heine Gymnasium in Kaiserslautern, where they completed their High School studies in 1989. Florian then attended the Max-Weber-Schule in Freiburg, Germany, where they earned their Bachelor's Degree in Public Business Assistant (BA) in 1991. That same year, they began studying at the Baden-Wuerttemberg Cooperative State University (DHBW), where they earned their Bachelor's Degree in International Marketing in 1994. In 1999, they completed the B. Braun Executive Management Program at USW - Schloss Gracht, where they studied Business Administration, Management and Operations. In 2000, they earned their Master of Science in Marketing from the University at Albany, SUNY. From 2004 to 2007, they completed a Diploma in Semiología de la Vida Cotidiana at the Instituto de Semiología in Mexico City, Mexico. In 2012, they earned a Diploma in Enneagram in Business from Institut Regard9 in Nantes, France. In 2014, they completed the Olympus Management Excellence Program in Ireland, where they earned a Diploma in the Joint Academic Program.